165 related articles for article (PubMed ID: 10606966)
21. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
[TBL] [Abstract][Full Text] [Related]
22. Similar binding properties for a neutralizing anti-tetanus toxoid human monoclonal antibody and its bacterially expressed Fab.
Lafaye P; Nato F; Mazié JC; Doyen N
Res Immunol; 1995; 146(6):373-82. PubMed ID: 8719661
[TBL] [Abstract][Full Text] [Related]
23. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
24. Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.
Mageed RA; Harmer IJ; Wynn SL; Moyes SP; Maziak BB; Brüggemann M; MacKworth-Young CG
Clin Exp Immunol; 2001 Jan; 123(1):1-8. PubMed ID: 11167990
[TBL] [Abstract][Full Text] [Related]
25. Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope.
Deroo S; Fischer A; Beaupain N; Counson M; Boutonnet N; Pletinckx J; Loverix S; Beirnaert E; De Haard H; Schmit JC; Lasters I
Mol Immunol; 2008 Mar; 45(5):1366-73. PubMed ID: 17936360
[TBL] [Abstract][Full Text] [Related]
26. The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values.
Ito W; Sakato N; Fujio H; Yutani K; Arata Y; Kurosawa Y
FEBS Lett; 1992 Aug; 309(1):85-8. PubMed ID: 1511750
[TBL] [Abstract][Full Text] [Related]
27. CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity.
Iwahashi M; Milenic DE; Padlan EA; Bei R; Schlom J; Kashmiri SV
Mol Immunol; 1999; 36(15-16):1079-91. PubMed ID: 10698310
[TBL] [Abstract][Full Text] [Related]
28. Human polyreactive and monoreactive antibodies: effect of glycosylation on antigen binding.
Donadel G; Calabro A; Sigounas G; Hascall VC; Notkins AL; Harindranath N
Glycobiology; 1994 Aug; 4(4):491-6. PubMed ID: 7827411
[TBL] [Abstract][Full Text] [Related]
29. Conversion of an anti-single-stranded DNA active site to an anti-fluorescein active site through heavy chain complementarity determining region transplantation.
Gulliver GA; Bedzyk WD; Smith RG; Bode SL; Tetin SY; Voss EW
J Biol Chem; 1994 Mar; 269(11):7934-40. PubMed ID: 8132513
[TBL] [Abstract][Full Text] [Related]
30. Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.
Shanehbandi D; Majidi J; Kazemi T; Baradaran B; Aghebati-Maleki L
Hum Antibodies; 2017; 26(1):1-6. PubMed ID: 28269762
[TBL] [Abstract][Full Text] [Related]
31. Isolated VH4 heavy chain variable regions bind DNA characterization of a recombinant antibody heavy chain library derived from patient(s) with active SLE.
Kieber-Emmons T; von Feldt JM; Godillot AP; McCallus D; Srikantan V; Weiner DB; Williams WV
Lupus; 1994 Oct; 3(5):379-92. PubMed ID: 7841991
[TBL] [Abstract][Full Text] [Related]
32. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
[TBL] [Abstract][Full Text] [Related]
33. Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin.
Song Z; Cai Y; Song D; Xu J; Yuan H; Wang L; Zhu X; Lin H; Breitling F; Dübel S
Hybridoma; 1997 Jun; 16(3):235-41. PubMed ID: 9219033
[TBL] [Abstract][Full Text] [Related]
34. Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma.
Mahendra A; Gangadharan B; André S; Boudjoghra M; Davi F; Lecerf M; Planchais C; Kaveri SV; Lacroix-Desmazes S; Dimitrov JD
Mol Immunol; 2014 Jul; 60(1):54-61. PubMed ID: 24769492
[TBL] [Abstract][Full Text] [Related]
35. Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.
Boughter CT; Borowska MT; Guthmiller JJ; Bendelac A; Wilson PC; Roux B; Adams EJ
Elife; 2020 Nov; 9():. PubMed ID: 33169668
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
37. Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain.
Xiang J; Chen Z; Delbaere LT; Liu E
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():239-47. PubMed ID: 8225393
[TBL] [Abstract][Full Text] [Related]
38. Deletion in HCDR3 rescues T15 antibody mutants from a secretion defect caused by mutations in HCDR2.
Martin TM; Kowalczyk C; Stevens S; Wiens GD; Stenzel-Poore MP; Rittenberg MB
J Immunol; 1996 Nov; 157(10):4341-6. PubMed ID: 8906808
[TBL] [Abstract][Full Text] [Related]
39. Real-time biospecific interaction analysis of a natural human polyreactive monoclonal IgM antibody and its Fab and scFv fragments with several antigens.
Roggenbuck D; König H; Niemann B; Schoenherr G; Jahn S; Porstmann T
Scand J Immunol; 1994 Jul; 40(1):64-70. PubMed ID: 8029645
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies in mice lacking terminal deoxynucleotidyl transferase: evidence for a role of N region addition in the polyreactivity and in the affinities of anti-DNA antibodies.
Weller S; Conde C; Knapp AM; Levallois H; Gilfillan S; Pasquali JL; Martin T
J Immunol; 1997 Oct; 159(8):3890-8. PubMed ID: 9378977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
